Descriptor English: | Maprotiline | ||||
Descriptor Spanish: |
Maprotilina
| ||||
Descriptor Portuguese: | Maprotilina | ||||
Descriptor French: | Maprotiline | ||||
Entry term(s): |
Ba-34,276 Ba34,276 Deprilept Dibencycladine Hydrochloride, Maprotiline Ludiomil Maprolu Maprotilin Maprotilin Holsten Maprotilin TEVA Maprotilin neuraxpharm Maprotilin ratiopharm Maprotilin-TEVA Maprotilin-neuraxpharm Maprotilin-ratiopharm Maprotiline Hydrochloride Maprotiline Mesylate Mesylate, Maprotiline Mirpan N-Methyl-9,10-ethanoanthracene-9(10H)-propylamine Novo Maprotiline Novo-Maprotiline Psymion maprotilin von ct |
||||
Tree number(s): |
D02.455.426.559.847.117.600 D04.615.125.600 |
||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D008376 | ||||
Scope note: | A bridged-ring tetracyclic antidepressant that is both mechanistically and functionally similar to the tricyclic antidepressants, including side effects associated with its use. |
||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||
Pharm Action: |
Antidepressive Agents, Second-Generation Adrenergic Uptake Inhibitors |
||||
Registry Number: | 2U1W68TROF | ||||
CAS Type 1 Name: | 9,10-Ethanoanthracene-9(10H)-propanamine, N-methyl- | ||||
Previous Indexing: |
Anthracenes (1972-1974) Propylamines (1972-1974) |
||||
Public MeSH Note: | 91; was see under ANTHRACENES 1975-90 |
||||
History Note: | 91(75); was see under ANTHRACENES 1975-90 |
||||
DeCS ID: | 8548 | ||||
Unique ID: | D008376 | ||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
Date Established: | 1991/01/01 | ||||
Date of Entry: | 1974/11/19 | ||||
Revision Date: | 2016/07/01 |
-
-
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Polycyclic Compounds [D04]Polycyclic Compounds
|
Maprotiline
- Preferred
Psymion
- Narrower
Ludiomil
- Narrower
Maprolu
- Narrower
Maprotilin Holsten
- Narrower
maprotilin von ct
- Narrower
Maprotilin-neuraxpharm
- Narrower
Maprotilin-ratiopharm
- Narrower
Maprotilin-TEVA
- Narrower
Maprotiline Hydrochloride
- Narrower
Maprotiline Mesylate
- Narrower
Mirpan
- Narrower
Novo-Maprotiline
- Narrower
Ba-34,276
- Narrower
Deprilept
- Narrower
Concept UI |
M0013021 |
Scope note | A bridged-ring tetracyclic antidepressant that is both mechanistically and functionally similar to the tricyclic antidepressants, including side effects associated with its use. |
Preferred term | Maprotiline |
Entry term(s) |
Dibencycladine Maprotilin N-Methyl-9,10-ethanoanthracene-9(10H)-propylamine |
Concept UI |
M0474725 |
Preferred term | Psymion |
Concept UI |
M0013020 |
Preferred term | Ludiomil |
Concept UI |
M0474726 |
Preferred term | Maprolu |
Concept UI |
M0474718 |
Preferred term | Maprotilin Holsten |
Concept UI |
M0474719 |
Preferred term | maprotilin von ct |
Concept UI |
M0474720 |
Preferred term | Maprotilin-neuraxpharm |
Entry term(s) |
Maprotilin neuraxpharm |
Concept UI |
M0474721 |
Preferred term | Maprotilin-ratiopharm |
Entry term(s) |
Maprotilin ratiopharm |
Concept UI |
M0474722 |
Preferred term | Maprotilin-TEVA |
Entry term(s) |
Maprotilin TEVA |
Concept UI |
M0330109 |
Preferred term | Maprotiline Hydrochloride |
Entry term(s) |
Hydrochloride, Maprotiline |
Concept UI |
M0330110 |
Preferred term | Maprotiline Mesylate |
Entry term(s) |
Mesylate, Maprotiline |
Concept UI |
M0474723 |
Preferred term | Mirpan |
Concept UI |
M0474724 |
Preferred term | Novo-Maprotiline |
Entry term(s) |
Novo Maprotiline |
Concept UI |
M0013022 |
Preferred term | Ba-34,276 |
Entry term(s) |
Ba34,276 |
Concept UI |
M0474717 |
Preferred term | Deprilept |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey